By combining both netarsudil and latanoprost treatment, Roclanda reduces intraocular pressure
News
Chemspace and Arrayjet link up to boost drug discovery
The partnership will expand Arrayjet’s small molecule microarray drug discovery offerings
ADDF reflects on Eli Lilly’s donanemab
Company’s phase 3 research showed the importance of running biomarker-powered clinical trials
TauRx’s deliver Alzheimer’s disease therapy results
Company’s hydromethylthionine mesylate therapy reduced neurodegeneration during pivotal trial
Cannabinoid company expands into oncology
OCTP develops cannabinoid medicines and is looking at potential treatment of cancer malignancies
Positive data for Caribou Biosciences’ CB-010 candidate
CAR-T cell therapy being researched among patients with relapsed or refractory B cell non-Hodgkin lymphoma
Cumulus Neuroscience in partnership with the Universities of Bath and Bristol
Collaboration will focus on progressing test for early detection of Alzheimer’s dementia
Revvity opens scientific centre of excellence in Cambridge
Facility will deliver technology to scientists, helping them to translate genomic insights
Calliditas reveals pivotal setanaxib data
Results are from company’s phase 2 head and neck cancer trial with lead NOX inhibitor candidate
Tenpoint receives £10m from British Patient Capital
The company aims to deliver therapies that provide benefits to patients affected by eye diseases
Stada expands its European treatment portfolio
Company adds a number of additional brands from Sanofi following initial take overs in 2021
Sanofi’s Rezurock accepted in Scotland
Therapy treats patients with chronic graft-versus-host disease who have already received other treatments
Patients in UK get early access to GSK’s Jemperli
It concerns the treatment being combined with platinum-containing chemotherapy
Janssen reveals new Spravato data
Period to remission was shortened with esketamine nasal spray in both sub-groups within study
GSK’s Arexvy authorised by MHRA
Therapy is the first respiratory syncytial virus vaccine specifically developed for older adults
